Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

Intracranial hemorrhage (ICH) is considered a potentially severe complication of oral anticoagulants (OACs) and antiplatelet therapy (APT). Patients with atrial fibrillation (AF) who survived ICH present both an increased ischemic and bleeding risk. Due to its lethality, initiating or reinitiating O...

Full description

Bibliographic Details
Main Authors: Fabiana Lucà, Furio Colivicchi, Fabrizio Oliva, Maurizio Abrignani, Giorgio Caretta, Stefania Angela Di Fusco, Simona Giubilato, Stefano Cornara, Concetta Di Nora, Andrea Pozzi, Irene Di Matteo, Anna Pilleri, Carmelo Massimiliano Rao, Antonio Parlavecchio, Roberto Ceravolo, Francesco Antonio Benedetto, Roberta Rossini, Raimondo Calvanese, Sandro Gelsomino, Carmine Riccio, Michele Massimo Gulizia
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrail fibrillation
oral anti coagulation
left atrial appendage (LAA) occlusion
intracranial hemorrhage
NOAC drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1061618/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1061618/full

Similar Items